HIV News and Research

RSS

State highlights: NYC soda fight back in court; doc training slots in N.Y.; Texas inmate dialysis costs

New York City's battle over sugary drinks is entering its endgame. But much more than soda is at stake. A plan to limit the sale of large, high-calorie beverages, championed by former Mayor Michael R. Bloomberg as a novel way to fight obesity, went before the State Court of Appeals here on Wednesday, the city's final recourse after a lower court judge struck down the proposal last year (Grynbaum, 6/4).

6 Jun 2014

Rice develops highly accurate test to detect signs of HIV

Rice University bioengineers are developing a simple, highly accurate test to detect signs of HIV and its progress in patients in resource-poor settings.

6 Jun 2014

Device used in physics and chemistry reveals dynamics of pervasive pathogen

If you have it, you probably don't know it. Cytomegalovirus, or CMV, is perhaps one of the biggest pathogens you've never heard of-big, both proportionately and epidemiologically.

6 Jun 2014

Merck enrolls first patient in reformulated raltegravir Phase 3 trial for treatment of HIV-1 infection

Merck, known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in the company's global Phase 3 clinical trial, ONCEMRK.

6 Jun 2014

Disinfection caps reduce CLABSI events by 68%

Thanks to the simple use of an alcohol-impregnated cap, Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period.

5 Jun 2014

Loyola achieves 68% decrease in central line-associated bloodstream infections

Loyola University Medical Center achieved a 68 percent decrease in the overall number of central line-associated bloodstream infections (CLABSI) over a 12-month period. A two-year study compared the use of disinfection caps to an intense scrub-the-hub intervention to standard care. Scrub-the-hub refers to cleaning catheter connector hubs and injection ports with alcohol for the recommended 15 seconds before accessing the central line, a catheter placed in a large vein to deliver medicine and liquids during hospitalization.

5 Jun 2014

New vaccine effective at preventing lung cancer in mice

Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is exceedingly effective at preventing the disease in mice.

4 Jun 2014

First Edition: June 3, 2014

Today's headlines include coverage of Medicare data released Monday indicating that 2012 charges for some common inpatient hospital procedures dramatically increased over the previous year.

From Medtronic 3 Jun 2014

State highlights: NYC plan for treating mentally ill; Kan. town gets abortion services again; Iowa medical marijuana

Mayor Bill de Blasio has asked several of his commissioners and aides to provide him with a plan by September to reduce the rate of incarceration among New Yorkers with mental illness. The effort, which City Hall will announce on Monday, is the administration's first major criminal justice initiative. Named the Task Force on Behavioral Health and the Criminal Justice System, it will include recommendations from the police and correction commissioners, the Manhattan district attorney, hospital administrators and judges (Goldstein, 6/1).

3 Jun 2014

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics, the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors.

From Quest Diagnostics 2 Jun 2014

HCV reactivation may not worsen survival outcomes for lymphoma patients with HIV

More than a quarter of HIV+ patients are also infected with the Hepatitis C virus (HCV), which may complicate treatment and care decisions after a cancer diagnosis. The specifics of those complications haven't been well-researched in the past. Results from a new Fox Chase Cancer Center study on this patient population may start filling in that gap.

31 May 2014

CIRM grants $5.6 million to develop HIV/AIDS therapeutic using Sangamo's ZFN genome-editing technology

Sangamo BioSciences, Inc. announced that the California Institute for Regenerative Medicine (CIRM) has granted a $5.6 million Strategic Partnership Award to fund clinical studies at City of Hope to develop a potentially curative ZFP Therapeutic for HIV/AIDS based on the application of Sangamo's zinc finger nuclease (ZFN) genome-editing technology in hematopoietic stem/progenitor cells (HSPCs).

31 May 2014

Health advocates allege 4 Fla. insurers discriminate against HIV patients

In a complaint to federal officials, the groups say the companies set high out-of-pocket costs for drugs to treat HIV and AIDS in an effort to discourage gay patients from picking the plans.

31 May 2014

Patients with AIDS-related lymphomas may face increased risk of CNSi

Patients with AIDS-related lymphomas (ARL) may face an increased risk of central nervous system involvement (CNSi) compared to other lymphomas. The effect of CNSi on survival outcomes, however, hasn't been thoroughly examined until now.

31 May 2014

First Edition: May 30, 2014

Today's headlines include the latest reports about the problems with the VA health system. Kaiser Health News staff writer Julie Rovner reports: "It's not just veterans who are having trouble with health care.

30 May 2014

Inovio Pharmaceuticals’ reverse stock split to become effective on June 5, 2014

Inovio Pharmaceuticals, Inc. today announced that its previously announced 1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

30 May 2014

State highlights: Complaint says Fla. plans tried to keep out AIDS patients; Ill. restores some Medicaid services; Fla. Gov. to sue feds

Four Florida insurance companies offering Affordable Care Act policies are discriminating against people with HIV or AIDS, according to two health-rights organizations that plan to file a formal complaint with the federal government Thursday.

30 May 2014

TSRI scientists receive more than $13M to design effective HIV vaccine

A team led by scientists at The Scripps Research Institute (TSRI) has received a grant of more than $13 million from the National Institute of Allergy and Infectious Disease of the National Institutes of Health to study antibodies to the human immunodeficiency virus (HIV)—which will play an essential role in the creation of any effective vaccine against HIV.

30 May 2014

Longer looks: 'Abandoning' patients; commiting people with mental illness; treating PTSD

For years I had tried and failed to understand why so many of my physician colleagues persisted in ordering tests, procedures, and treatments that seemed to provide no benefit to patients and even risked harming them.

30 May 2014

Researchers create experimental blood test that determines BHI by gauging performance of mitochondria

Researchers at the University of Alabama at Birmingham School of Medicine have created an experimental blood test that, for the first time, determines a "Bioenergetic Health Index," or BHI, by gauging the performance of mitochondria, the cell's energy powerhouses.

30 May 2014

HIV News and Research

State highlights: NYC soda fight back in court; doc training slots in N.Y.; Texas inmate dialysis costs

Rice develops highly accurate test to detect signs of HIV

Device used in physics and chemistry reveals dynamics of pervasive pathogen

Merck enrolls first patient in reformulated raltegravir Phase 3 trial for treatment of HIV-1 infection

Disinfection caps reduce CLABSI events by 68%

Loyola achieves 68% decrease in central line-associated bloodstream infections

New vaccine effective at preventing lung cancer in mice

First Edition: June 3, 2014

State highlights: NYC plan for treating mentally ill; Kan. town gets abortion services again; Iowa medical marijuana

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

HCV reactivation may not worsen survival outcomes for lymphoma patients with HIV

CIRM grants $5.6 million to develop HIV/AIDS therapeutic using Sangamo's ZFN genome-editing technology

Health advocates allege 4 Fla. insurers discriminate against HIV patients

Patients with AIDS-related lymphomas may face increased risk of CNSi

First Edition: May 30, 2014

Inovio Pharmaceuticals’ reverse stock split to become effective on June 5, 2014

State highlights: Complaint says Fla. plans tried to keep out AIDS patients; Ill. restores some Medicaid services; Fla. Gov. to sue feds

TSRI scientists receive more than $13M to design effective HIV vaccine

Longer looks: 'Abandoning' patients; commiting people with mental illness; treating PTSD

Researchers create experimental blood test that determines BHI by gauging performance of mitochondria

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News